| P2093 | author name string | James R Sowers | |
| | Bysani Chandrasekar | |
| | Gerald A Meininger | |
| | Ravi Nistala | |
| | Annayya R Aroor | |
| | Vincent G DeMarco | |
| | Cassandra E Smith | |
| | Shawn B Bender | |
| | Scott M Brown | |
| | Alex I Meuth | |
| | Maloree Khan | |
| | Hannah M Cleeton | |
| P2860 | cites work | Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes | Q82787527 |
| | Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction | Q83285665 |
| | Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α | Q86488169 |
| | Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice | Q86916012 |
| | Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart | Q87349316 |
| | Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrains | Q87457408 |
| | Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats | Q89156034 |
| | Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling | Q22009382 |
| | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 |
| | CIKS, a connection to Ikappa B kinase and stress-activated protein kinase | Q24290148 |
| | Act1, an NF-kappa B-activating protein | Q24654030 |
| | Diabetic cardiomyopathy: bench to bedside | Q26997062 |
| | Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure. | Q27340146 |
| | Trends in prevalence and outcome of heart failure with preserved ejection fraction | Q28252937 |
| | Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus | Q28297680 |
| | Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice | Q33644666 |
| | Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice | Q33750640 |
| | Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4. | Q33902466 |
| | Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity | Q34027687 |
| | Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system | Q34062829 |
| | Application of atomic force microscopy measurements on cardiovascular cells | Q34119818 |
| | Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor | Q34219918 |
| | Ectonucleotidase CD38 demarcates regulatory, memory-like CD8+ T cells with IFN-γ-mediated suppressor activities | Q34428428 |
| | N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats | Q34554693 |
| | Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology | Q35175554 |
| | Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness | Q35390440 |
| | Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus | Q35411329 |
| | Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice | Q35738015 |
| | Regional variation in arterial stiffening and dysfunction in Western diet-induced obesity. | Q35958598 |
| | Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro | Q36096985 |
| | Endothelial Mineralocorticoid Receptors Differentially Contribute to Coronary and Mesenteric Vascular Function Without Modulating Blood Pressure | Q36143316 |
| | Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells | Q36229116 |
| | Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis | Q36289289 |
| | Role of angiotensin II in the evolution of diastolic heart failure | Q36332211 |
| | CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy | Q36337179 |
| | CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction. | Q36711861 |
| | CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis | Q36882248 |
| | Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats | Q36946065 |
| | Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration | Q36957712 |
| | Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure | Q37090864 |
| | Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. | Q37258157 |
| | Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. | Q37387706 |
| | An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease | Q38053516 |
| | Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling | Q38380871 |
| | Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial | Q38424163 |
| | Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review | Q38592514 |
| | Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system | Q38751579 |
| | Role of bone marrow-derived CD11c+ dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy | Q38872059 |
| | Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling | Q39039959 |
| | Understanding memory CD8+ T cells | Q39169186 |
| | Regular Exercise Reduces Endothelial Cortical Stiffness in Western Diet-Fed Female Mice. | Q39443264 |
| | Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction | Q39514603 |
| | Excessive Adventitial Remodeling Leads to Early Aortic Maladaptation in Angiotensin-Induced Hypertension. | Q40241638 |
| | Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes | Q40534109 |
| | Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine | Q40580301 |
| | Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin αVβ3/nuclear factor-κB/interleukin-6 axis. | Q40665021 |
| | Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction. | Q41049541 |
| | Nonclassical resident macrophages are important determinants in the development of myocardial fibrosis | Q41186913 |
| | Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure. | Q42050075 |
| | Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension | Q42784122 |
| | Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure | Q47959283 |
| | Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2. | Q48078654 |
| | MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway | Q50990734 |
| | Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? | Q51033306 |
| | Cutting edge: programmed death-1 defines CD8+CD122+ T cells as regulatory versus memory T cells. | Q51050277 |
| | Stimulation of T-Cell activation by CXCL12/stromal cell derived factor-1 involves a G-protein mediated signaling pathway. | Q52011943 |
| | Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats. | Q53022208 |
| | Depletion of CD8+ T Cells Exacerbates CD4+ T Cell-Induced Monocyte-to-Fibroblast Transition in Renal Fibrosis. | Q53207921 |
| | Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats. | Q53520949 |
| | Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy. | Q54215442 |
| | Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life. | Q54423601 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diastole | Q492905 |
| | Diastolic function | Q30314111 |
| P304 | page(s) | 3592-3604 | |
| P577 | publication date | 2017-10-01 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice | |
| P478 | volume | 158 | |